Pathways of airway oxidant formation by house dust mite allergens and viral RNA converge through myosin motors, pannexons and Toll-like receptor 4. by Zhang, J et al.
ORIGINAL RESEARCH
Pathways of airway oxidant formation by house dust mite
allergens and viral RNA converge through myosin motors,
pannexons and Toll-like receptor 4
Jihui Zhang1, Jie Chen1, Shannon C. Mangat1, Chathuri Perera Baruhupolage1, David R. Garrod2, &
Clive Robinson 1
1Institute for Infection and Immunity, St George's, University of London, London, UK
2Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
Keywords
Airway epithelium, cysteine protease, house
dust mite allergens, pannexons, reactive
oxidant species, toll-like receptor 4
Correspondence
Clive Robinson, Institute for Infection and
Immunity, St George's, University of London,
London, UK.
Tel: þ44 (0) 20 8725 5620;
Fax: þ44 (0) 20 8725 0685;
E-mail: c.robinson@sgul.ac.uk
Funding information
This work was supported by the Wellcome
Trust (Award 087650, to CR).
Received: 12 October 2017; Revised: 1
February 2018; Accepted: 6 February 2018
Immunity, Inflammation and Disease
(2018)
doi: 10.1002/iid3.216
Jihui Zhang and Jie Chen contributed equally
to this work.
Present address of Jihui Zhang: State Key
Laboratory of Microbial Resources, Institute of
Microbiology, Chinese Academy of Sciences,
Beijing, P.R. China.
Abstract
Introduction: Intracellular reactive oxidant species (ROS) are generated in human
airway epithelial cells by the prothrombinase action of Group 1 house dust mite
(HDM) allergens and by ligation of viral RNA sensor Toll-like receptors (TLRs).
We explored signaling convergence between HDM allergens and TLRs in ROS
generation because epithelial cells form the primary barrier against inhaled
substances and dictate host responses to allergens and viruses.
Methods: ROS formation by Calu-3 human airway cells was studied by measuring
dihydrorhodamine 123 oxidation after activation by polyinosinic:polycytidylic
acid (to activate TLR3), CL097 (to activate TLR7), a natural mixture of HDM
allergens, or BzATP.
Results: TLR4 activation was identified as an indispensable response element for all
stimuli, operating downstream from myosin motor activation, pannexon gating
for ATP release and the endogenous activation of prothrombin. Exogenous
prothrombin activation by HDM allergens was prevented by SGUL 1733, a novel
inhibitor of the proteolytic activity of Group 1 HDM allergens, which thus
prevented TLR4 from being activated at source.
Conclusions: Our data identify for the first time that endogenously-generated
prothrombin and TLR4 form a shared effector mechanism essential to intracellular
ROS generation activated by a group 1 HDM allergen (itself a prothrombinase) or
by ligation of viral RNA-sensing TLRs. These stimuli operate a confluent signaling
pathway in which myosin motors, gating of pannexons, and ADAM 10 lead to
prothrombin-dependent activation of TLR4 with a recycling activation of
pannexons.
Introduction
The archetype of Group 1 house dust mite (HDM) allergens,
Der p 1, is an inhalant allergen of global clinical significance.
It is a potent stimulus for the intracellular production of
reactive oxidant species (ROS) in human airway epithelial
cells and the most significant component in the constellation
of HDM allergens with this bioactivity [1–3]. This ROS
generation which is inter alia of mitochondrial origin, is an
innate response to the allergen and is triggered as a
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consequence of the recently discovered prothrombinase
character of Der p 1 [3]. Group 1 HDM allergens are cysteine
peptidases with highly conserved identities and functional
activities across HDM species [1] so it is reasonable to infer
from the behaviour of Der p 1, the group 1 allergen from
Dermatophagoides pteronyssinus, that this prothrombinase
activity is exhibited by all Group 1 HDM allergens.
Consequently, all Group 1 HDM allergens are vulnerable
to Allergen Delivery Inhibitor (ADI) drugs which have been
designed as a novel inhaled approach asthma treat-
ment [1–3]. The generation of thrombin by Der p 1 liberates
the canonical activator of protease activated receptor (PAR)
1 and PAR 4 and is necessary for ROS production [3]. The
full blockade of ROS production by antagonism of either
receptor suggests that these PARs are activated as hetero-
dimers or hetero-oligomers [3], analogous to a behavior
identified in platelets [4, 5].
Downstream from the activation of PAR 1 and PAR 4 by
the Der p 1-thrombin axis is the release of ATP through
pannexon channels [3, 6]. Additional elements of the
signaling between Der p 1 and ROS generation have been
defined and include a major role for a disintegrin and
metalloprotease (ADAM) 10 [6]. The ability of Der p 1 to
trigger ROS production innately through a thrombin-
dependent mechanism casts new light on how allergens
directly influence the Th2 bias of immune responses and
have the potential to drive the proliferation of smooth
muscle [3, 6]. ROS induce histone modifications and the
activation of redox-sensitive transcription factors which
promote pro-allergic cytokines. Furthermore, by direct
protein modification they activate signal transduction
cascades (e.g., mitogen-activated protein kinases and the
signal transducer and activation of transcription family)
associated with allergy and asthma [7].
One notable aspect of epithelial ROS is their ability to
regulate the release of interleukin 33 (IL-33) which is
enhanced in asthma [8, 9]. Significantly, constitutive IL-33
and the Th2 responses it directs inhibit innate defence
against respiratory viruses [3, 8, 10]. Intriguingly, we
previously identified intracellular ROS production in
epithelial cells which was dependent upon ATP release
following the stimulation of the viral RNA sensors Toll-like
receptor (TLR) 3, melanoma differentiation associated
protein-5 (MDA-5) and retinoic acid inducible gene-I
(RIG-I) [3]. Similarities between ROS generation initiated
by virus detection and HDM allergens are interesting
because interactions between asthma triggers and respiratory
viruses are risk factors for asthma exacerbations. In this
context it is significant that anti-oxidant deficits are
established risk factors for asthma and correlate with asthma
severity [7, 11].
Studies in mice identify TLR4 expression in the airway
epithelium as indispensable for allergic sensitisation and
implicate it as an activator of IL-1a production which
triggers the autocrine release of granulocyte-macrophage
colony stimulating factor (GM-CSF) and IL-33 [12, 13]. As
IL-33 release is ROS-regulated, in part, by NADPH oxidase
dual oxidase 1 (DUOX1) whose activity is elevated in allergic
disease [9], we were interested to explore the activation of
TLR4 by signaling mechanisms operated by Der p 1 and
ligation of viral RNA-sensing TLRs. Specifically, we sought
to define components leading to TLR4 activation and
postulated that pannexons, and their associated mechanisms
that gate ATP release, are key points where convergence
between allergen and viral RNA stimuli might create a
confluent pathway to TLR4 activation.
Methods
Chemicals and reagents
CL 097 (2-(ethoxymethyl)-1H-imidazo(4,5-c)quinolin-4-
amine) was from InVivogen (Toulouse, France). TAK-242,
(ethyl-(6R)-6-(N-(2-chloro-4-fluorophenyl)sulphamoyl)
cyclohex-1-ene-1-carboxylate was from Merck Millipore
(Watford, Hertfordshire, UK). ML7 (hexahydro-1-[(5-
iodo-1-naphthalenyl)sulphonyl]-1H-1,4-diazepine hydro-
chloride); glycyl H1152 ((S)-(þ)-4-glycyl-2-methyl-1-[(4-
methyl-5-isoquinolinyl)sulphonyl]-hexahydro-1H-1,4-dia-
zepine dihydrochloride; GI 254023X ((2R)-N-[(1S)-2,2-
dimethyl-1-[(methylamino)carbonyl]propyl]-2-[(1S)-1-
(N-hydroxyformamido)ethyl]-5-phenylpentanamide);
AG1478 (N-(3-chlorophenyl)-6,7-dimethoxy-4-quinazoli-
nanine hydrochloride); CP 690550 ((3R,4R)-4-methyl-3-
(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-b-oxo-1-
piperidinepropanenitrile citrate, and AZ10606120 (N-[2-
[[2-[(2-hydroxyethyl)amino]ethyl]amino]-5-quinolinyl]-
2-tricyclo[3.3.1.13,7]dec-1-ylacetamide dihydrochloride
were obtained from Tocris (Avonmouth, Bristol, UK).
Argatroban ((2R,4R)-1-[(2S)-5-[(aminoiminomethyl)
amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quino-
linyl)sulphonyl]amino]pentyl]-4-methyl-2-piperidinecar-
boxylic acid; formoterol fumarate dihydrate ((R,R)-N-[2-
hydroxy-5-[1-hydroxy-2-[[2-(4-methoxyphenyl)-1-meth-
ylethyl]amino]ethyl]phenyl]formamide; salbutamol (a1-
[[(1,1-dimethylethyl)amino]methyl]-4-hydroxy-1,3-benze-
nedimethanol hemisulphate); BzATP (20(30)-O-(4-benzoyl-
benzoyl)adenosine 50-triphosphate triethylammonium salt);
UTP (uridine-50-triphosphate); cycloheximide and mon-
ensin were from Sigma–Aldrich, Poole, Dorset, UK.
Dihydrorhodamine-123 was obtained from Life Technolo-
gies (Paisley, Renfrewshire, UK). SGUL 1773 (N-((S)-1-
(((S)-1-(((S)-1-(benzylamino)-4-methyl-1,2-dioxopentan-
3-yl)amino)-oxopropan-2-yl)amino)-3,3-dimethyl-1-oxo-
butan-2-yl) benzamide), a potent (Ki <5 nM) and selective
inhibitor of Der p 1 and other Group 1 HDM allergens was
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synthesized as described in our previous work [2]. This
compound has no significant inhibitory activity against
thrombin (IC50> 100 mM).
Polyinosinic:polycytidylic acid, 1.5–8 kb (InvivoGen), was
used routinely, with comparative studies being made with a
shorter form of poly i:c (0.2–1 kb) where stated. Antibodies
for use in fluorescent antibody labeling or western blotting
were from AbD Serotec (Kidlington, Oxfordshire, UK),
Abcam (Cambridge, UK), and Insight Biotechnology
(London, UK). An Alexa 488-conjugated secondary anti-
body for immunofluorescence detection was from Life
Technologies. Consumables for SDS–PAGE and immuno-
blotting were from InVitrogen/ThermoFisher (Paisley,
Renfrewshire, UK) and GE Healthcare (Little Chalfont,
Buckinghamshire, UK). Fluorescent antibody labeling and
immunoblotting were performed conventionally. TLR3 and
TLR4 were immunoblotted using polyclonal antibodies
directed against, respectively, a 15 amino acid synthetic
peptide from the carboxy terminus and an epitope
corresponding to residues 242–321 in the human receptors.
TLR7 was detected by blotting using a monoclonal antibody
raised against recombinantly expressed residues 451–500
from the human receptor sequence. Immunoblotting of
pannexin-1 was undertaken using a polyclonal antibody
directed against a conjugate of residues found within the
span 150–250 in the human protein. Detection of EGFR
employed a monoclonal antibody raised against a recombi-
nant protein corresponding to amino acids 363–499 in the
human sequence. MYLK was immunoblotted using a
monoclonal antibody directed to a human peptide sequence
and which is known to detect non-muscle MYLK isoforms.
Immunoblotting of prothrombin was undertaken with a
polyclonal antibody raised against full length protein from
human plasma. ADAM 10 was detected by monoclonal
antibody raised against residues 1–300 of the human
enzyme, while ADAM 17 was immunoblotted using a
polyclonal antibody directed against a synthetic peptide
from the C-terminus sequence. All immunoblotting was
performed with sample loadings normalized for protein
concentration.
Cell culture media and reagents were obtained from Life
Technologies, Sigma–Aldrich, and GE Healthcare. Transfec-
tion reagents and siRNA duplexes for gene silencing studies
(usually these were mixtures of 3 target-specific 19–25 nt
siRNAs or scrambled controls against no known targets)
were provided by Insight Biotechnology.
HDM allergen harvesting and Der p 1 purification
D. pteronyssinus HDM were maintained in continuous solid-
phase culture under barrier conditions with controlled
temperature (258C) and relative humidity (75%) in custom-
engineered containment. Mixed, native HDM allergens in
their natural proportions were prepared according to our
routine processes. ELISA measurements (Indoor Biotech-
nologies, Cardiff, UK) were used to determine the Der p 1
content of the allergen extracts, whilst the catalytic activity of
Der p 1 was quantified as described elsewhere using a
fluorescence resonance energy transfer substrate designed
for Der p 1 [2, 14]. We elected to use mixed HDM allergens
for the majority of these studies because this presentation is
most representative of the material to which the airway
epithelium is exposed in life. HDM mixtures were
normalized by reference to Der p 1 content expressed as
mg/mL  1 as previously described [3]. Thus ‘HDM 1’ is
equivalent to 1 mg/mL  1 Der p 1 and so forth. For consistent
batch to batch proteolytic activity of Der p 1 in allergen
preparations, experiments were conducted in the presence of
5 mM L-cysteine which was present also in vehicle controls
in these experiments.
To provide a source of reference Der p 1 and to generate
protein for confirmatory studies, the mixed HDM allergens
were used as feedstock for protein purification. Der p 1 was
purified from harvested mite culture medium at 48C by
adding 2–3 volumes of Dulbecco’s PBS followed by
overnight stirring. The supernatant was collected after
centrifugation (30 min, 24,000g, 48C) and solid ammonium
sulphate added to 50% saturation in the presence of 1 mM
EDTA. Pellets were collected by centrifugation after a
minimum of 2 h precipitation. Insoluble matter was
removed from the reconstituted solution and the soluble
fraction then subjected to size exclusion chromatography on
an €AktaPurifier system (HiPrep 16/60 Sephacryl S-200 HR,
GE Healthcare) in elution buffer (0.2 M sodium phosphate
containing 0.5 M sodium chloride and 1 mM EDTA, pH
7.4). A fraction with retention volume 90–120 mL was
collected and eluted through a soybean trypsin inhibitor
(SBTI) column. After concentrating the eluate it was re-
chromatographed on Sephacryl S-200 with a further round
of SBTI affinity chromatography. The eluate from this was
then concentrated and desalted using an Amicon ultrafiltra-
tion cell (Millipore, Bedford, MA) equipped with 10 kDa
cut-off membrane. The desalted concentrate was diluted
into 20 mM Tris-HCl buffer, pH 8.0, for €AktaPurifier
chromatography on Resource Q (GE Healthcare) from
which Der p 1 was eluted by a 0–0.5 M sodium chloride
gradient. Peaks containing Der p 1 were analyzed by SDS–
PAGE and MALDI-TOF mass spectrometry (Bruker Flex,
Bruker, Coventry, UK) and combined. The quantity of Der p
1 was determined in a quartz cuvette by absorbance at
280 nm using an extinction coefficient of 47,705 M  1 cm  1.
Cell culture and transfection
Calu-3 cells were cultured according to standard methods
previously disclosed [15–17]. This cell line preserves the
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integrity of tight junctions (TJs) and readily forms polarized
monolayers which develop substantial transepithelial resis-
tance [15, 16]. Our extensive prior work has established that
this cell line responds to HDM allergens through a variety of
mechanisms also shown to operate in primary cultures of
human airway epithelial cells [17–20]. Notably, intracellular
ROS generation which is dependent upon the cleavage of
PAR1 and PAR4 by Der p 1 is a feature we have already
identified in primary cultures from human lung and in other
immortalized epithelial cell lines from human airway [3].
Gene silencing experiments with siRNA duplexes were
performed according to the supplier protocol optimized for
these experiments. In some experiments it was observed that
the transfection process per se had small effects on the
maximal rate of oxidant of stimulated ROS production. For
the purposes of interpretation, the effects of active
interventions have been considered with reference to the
corresponding transfection controls and not the ‘‘clean’’
non-transfected controls.
Measurement of ROS production
ROS production was studied in cells plated into 96-well
format on clear-bottomed black culture plates (Corning,
Amsterdam, The Netherlands). Cells were washed and then
loaded for 15 min at ambient temperature with dihydro-
rhodamine–123 (10 mM) in phosphate buffered saline
(PBS), after which excess probe was removed by washing
and the PBS replaced by Hanks’ balanced salt solution
(HBSS) containing 20 mM 4-(2-hydroxyethyl)-1-piperazine
ethanesulphonic acid (HEPES). Where appropriate, cells
were then treated with inhibitors for 20 min at 378C prior to
the addition of stimulating agents (HDM allergen mixture,
purified Der p 1, poly i:c, CL 097, BzATP, or UTP). Drug
vehicles comprised HBSS/HEPES containing, where appro-
priate, any aprotic solvents used to stored concentrated
solutions of drug substances. Dilution schemes ensured that
only trace amounts of these solvents entered experiments.
Controls were also incorporated to examine compounds for
baseline effects on ROS generation.
Reactions were started by the addition of the stimulant
and maintained at 308C under constant humidity in an
Envision plate reader (Perkin Elmer, Seer Green, Bucking-
hamshire, UK) for the duration of the experiment.
Fluorescence measurements were made every 5 min (excita-
tion 485 nm, emission 535 nm) and the maximum rate of
oxidant production determined from the progress curves
(increase in fluorescence upon oxidation of dihydrorhod-
amine-123 to rhodamine) recorded for each well over a 2.5 h
period. The oxidative formation of rhodamine may be
accomplished by a range of reactive species generated by
different mechanisms, so without prejudice we electively
refer to these measurements as intracellular ROS to reflect
contributions from multiple sources. Advantageously,
dihydrorhodamine accumulates preferentially in mitochon-
dria and our previous work using a DNA-binding
triphenylphosphonium analogue of dihydroethidium and
a mitochondrial disruptor indicates that a component of this
ROS generation is of mitochondrial origin via formation of
O 2 [3]. Additionally, dihydrorhodamine is an effective
reporter of products formed by the facile, spontaneous
decomposition of peroxynitrite arising through the reaction
of O 2 with nitric oxide. Nitric oxide is formed in airway
epithelial cells as a consequence of ATP-dependent activa-
tion of P2X7 and P2Y2 receptors (our unpublished
observations). This observation does not preclude the
tandem formation of ROS derived from NOX/DUOX
activity in the response to allergen or viral RNA sensor
stimulation.
Standard concentrations of stimulants used for cell
activation were determined from previous experiments or
concentration-response relationships shown herein [3, 6]
and unpublished data). Experiments involving stimulation
by HDM allergen mixtures were routinely run using ‘‘HDM
1’’ for cell activation, but ROS generation is significant from
concentrations at least 100-fold lower. The relevance of this
concentration range is based upon modeling the deposition
and dissolution characteristics of HDM fecal pellets (which
contain the allergenic proteins) in the surface liquid of
human airways. Given the dimensions of the bronchial tree
of adults, and that from aerodynamic particle limitations
HDM fecal pellets are unlikely to penetrate beyond third
generation bronchi, the epithelial area exposed in real life
would be 143 cm2. Taking account of the rate of HDM
fecal pellet inhalation, the growth surface of a well in a
culture plate (96 well format) and corrections for the
differences in liquid height between culture conditions and
airway surface liquid, this suggests a well would require a
theoretical average of 400 HDM fecal pellet equivalents to
mimic natural exposure. However, the escalating rate of
inertial impaction in lower-generation airways will create
regional inhomogeneities where the actual allergen burden is
expected to be significantly in excess of the theoretical. From
ELISA determinations, taking an average mass amount of
Der p 1 in a single fecal pellet to be 0.1 ng, the theoretical
average exposure equates to 40 ng Der p 1 under the stated
conditions. This lies within the observed range of ROS
generating ability for calu-3 cells or primary cultures which
spans the range 2–200 ng Der p 1 per well [3, 6].
Statistical analyses
Unless stated otherwise, data are presented as mean s.e.m
(n¼ 8) in single experiments with cells from the same
passage. These experiments were repeated >3 times with
cells from different passages for confirmation and data were
TLR4, TLR3, and allergens in ROS generation J. Zhang et al.
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accepted only if repetition yielded similar outcomes, that is,
the inferences that could be drawn were the same. Graphical
representations have been made using bar and line charts for
visual simplicity and because analysis of scatter did not
reveal unusual or interesting aspects of the data not obvious
from this form of display. Significance was determined using
one-way analysis of variance with Newman–Keuls post hoc
testing in SigmaPlot v12. The threshold for statistical
significance was P< 0.05 but in the majority of cases group
differences exceeded this threshold and were highly
significant, that is, P< 0.001. For convenience, the labeling
scheme used in the Figures indicates P< 0.05 even when
analyses indicated higher levels of significance.
Ethical approval
No humans or animals were used in these experiments, so
formal ethical approvals were not required.
Results
TLR3-dependent ROS generation in airway
epithelial cells requires ATP and pannexin-1-
containing pannexons
Our initial approach was to investigate whether surrogates
of viral infection behaved like Der p 1 in evoking
intracellular ROS generation which was dependent upon
pannexon-gated ATP release [3]. Exposure of cells to poly
i:c, a ligand for TLR3 which acts as an endosomal sensor
for double-stranded viral RNA, resulted in a progressive
and sustained generation of ROS. We first investigated the
ability of poly i:c to generate ROS in an ATP-dependent
manner. To achieve this, cells were activated in the absence
or presence of the negative allosteric modulator of P2X7
receptors, AZ 10606120, which provided a potent blockade
of the response (Fig. 1A). For comparison, the effect of AZ
10606120 on responses to mixed HDM allergens is shown
in Figure 1B. At present, the reasons for the incomplete
inhibition of the response compared to cells stimulated
with poly i:c are unclear, but this may be a function of an
enduring cellular stimulation by the Group 1 protease
allergen component of the allergen mixture. Our forerun-
ner studies established that carbenoxolone, a well-estab-
lished inhibitor of signaling at connexons and pannexons,
also attenuated the response to mixed HDM allergens or
poly i:c (data not shown), consistent with ATP release/
intercellular transfer occurring through a channel-depen-
dent mechanism. The lack of selectivity of carbenoxolone
notwithstanding, a reasonable inference is that the channels
responsible for the AZ 10606120-inhibitable response are
pannexons rather than connexons, although additional
experiments are needed to confirm this. Nevertheless, this
interpretation is supported by the inhibition of poly i:c
response in cells in which pannexin-1 expression was
silenced by siRNA pre-treatment (Fig. 1C) and recalls our
previous work in which pannexin-1 expression was shown
to be crucial to the generation of intracellular ROS in
airway epithelial cells stimulated by mixed HDM aller-
gens [3]. Fluorescent antibody labeling confirmed the
presence of pannexin-1 in calu-3 cells which was expressed
in a reticular pattern with a significant cytoplasmic
background absent in labeling controls (Fig. 1D). Further
work will be necessary formally to investigate whether
connexon—mediated intracellular signaling contributes to
the propagation of these responses, but given the diversity
of connexin proteins this was considered beyond the scope
of the present investigation.
CL097-dependent activation of intracellular ROS
generation
Having established that TLR3 ligation evoked ROS genera-
tion which was pannexon-dependent, we then examined
whether ligation of a sensor for single-stranded RNA would
evoke a response. CL097, a ligand for TLRs 7 and 8 which
detect single-stranded viral RNA, elicited an increase in ROS
production which was concentration-dependent and com-
parable to that evoked by BzATP which was used as a positive
control (Fig. 2A). Inhibition by cycloheximide and
monensin indicated that the action of CL097 was dependent
upon protein synthesis and export (Fig. 2B), but the lack of
effect of CP 690550, which was consistent with previous
findings for poly i:c/TLR3 activation [3], suggested an
independence from JAK signaling (Fig. 2C). However, the
response was inhibited by AZ10606120 (Fig. 2D) and by
transient silencing of pannexin-1 expression (Fig. 2E). Gene
silencing of TLR7 caused a marked decrease in ROS
generation by CL097 (Fig. 2F).
MYLK involvement in pannexon-dependent ROS
generation
With evidence that pannexon-based signaling is an essential
feature of ROS generation by the ligation of viral RNA
sensors, we next investigated whether these channels were
being operated in a manner similar to that initiated by HDM
allergen stimulation. The gating of pannexons in non-
excitable tissues is not well understood, but may involve
mechanical stress. Therefore, we were interested to establish
whether ROS production activated by Der p 1, poly i:c or CL
097 involved myosin molecular motors and actin filaments.
To do this we reasoned that interventions designed to
prevent myosin light chain phosphorylation, either by
inhibiting the action of myosin light chain kinase (MYLK) or
Rho-associated coiled-coil kinases (ROCKs) which control
J. Zhang et al. TLR4, TLR3, and allergens in ROS generation
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the activity of myosin light chain phosphatase, should be
informative. The MYLK inhibitor ML7 was without effect on
baseline ROS production but blocked responses in cells
stimulated by HDM allergens, poly i:c or CL 097 (Fig. 3A–
C). The ROCK inhibitor glycyl H1152 had no effect on
baseline ROS production but it attenuated responses to
mixed HDM allergens or poly i:c (Fig. 3D,E). However, it
was ineffective against CL 097 (Fig. 3F). Transient silencing
with siRNA provided direct confirmation that MYLK-
regulated pathways are central to intracellular ROS genera-
tion activated by HDM allergen stimulation or the ligation of
TLR3 or TLR7 (Fig. 4A–C).
Figure 1. Intracellular ROS production by poly i:c depends on ATP release and pannexons. (A) Inhibition of poly i:c induced ROS generation by AZ
10606120 (P< 0.05 v vehicle control (veh), P< 0.05 v poly i:c). (B) Inhibition by AZ 10606120 of ROS production initiated by mixed HDM allergens
(P< 0.05 v veh; P< 0.05 v veh; †,‡P< 0.05 v corresponding HDM response). (C) Silencing of pannexin 1 (PNX-1) by siRNA inhibits ROS production by
poly i:c (P< 0.05 v veh, †P< 0.05 v poly i:c without control transfection (con), ‡P< 0.05 v poly i:c with or without control transfection). Inset image
shows immunoblot of PNX-1 in cells transfected with target siRNA or control siRNA (con). (D) Fluorescent antibody labeling of pannexin-1 in calu-3 cells.
The strip image depicts a negative staining control.
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Figure 2. Continued.
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As a further evaluation of the involvement of MYLK we
treated cells with b2-adrenoceptor agonists which are
known, amongst other actions which may have a bearing
on ROS production, to indirectly inhibit MYLK through its
protein kinase A-dependent phosphorylation. Formoterol
produced a concentration-dependent inhibition of all 3
stimuli (Fig. 4D–F), as did salbutamol albeit with lower
potency (not shown).
Viral RNA-sensing TLRs utilize ADAM 10 and EGFR
in ROS generation
The finding that the critical path to ROS production for all
stimuli requires MYLK activation and actomyosin suggests
that this step lies downstream from a point of signaling
convergence which creates a confluent signaling mechanism.
If correct, then other signaling events which appear
downstream of MYLK and pannexon gating should exhibit
similar conformity. Our previous work was the first to
establish a role for ADAM 10 in the activation of intracellular
ROS production by Group 1 HDM allergens [6], so we
investigated whether ADAM 10 had a similar involvement in
ROS generation in cells stimulated by ligation of viral RNA-
sensing receptors.
The selective inhibitor of ADAM 10, GI 254023X,
inhibited responses to both long and short forms of poly i:
c, with a greater efficacy against the latter which our
previous work [3] shows to be a more potent stimulant of
responses mediated via RIG-I (Fig. 5A,B). Activation of
ROS production by poly i:c was inhibited by the EGFR
tyrosine kinase inhibitor, AG 1478 (Fig. 5C), as were
responses to BzATP (Fig. 5D). In addition, responses to
BzATP were also blocked by GI 254023X (Fig. 5E). This
suggests that, as with responses to HDM allergen
stimulation reported elsewhere [6], the activation of
ADAM 10 and EGFR lie downstream of ATP release and
purinoceptor activation. ROS generation was prevented
from rising above baseline levels following siRNA
knockdown of either target (Fig. 5F), confirming the
importance of both ADAM 10 and EGFR in signaling
responses evoked by poly i:c. Knockdown of ADAM 17 was
also capable of attenuating ROS production by poly i:c
(Fig. 5G). Responses to CL 097 were similarly inhibited by
GI 254023X and by siRNA directed against ADAM 10 or
EGFR, consistent with intracellular ROS production
triggered by the activation of TLR7 sharing downstream
effectors with TLR3 responses (Fig. 6A–C).
TLR3 and TLR7-dependent ROS generation in
airway epithelial cells requires prothrombin and
thrombin
Treatment of cells with the thrombin inhibitor argatroban
strongly attenuated ROS generation by poly i:c or CL 097
(Fig. 7A,B), suggesting that stimulation of TLR3 or TLR7
evokes the endogenous generation of thrombin. This was
confirmed by siRNA silencing of prothrombin which
effectively prevented any response to BzATP, poly i:c or
CL 097 (Fig. 7C,D). While the recently-discovered pro-
thrombinase activity of Der p 1 establishes the rationale for
thrombin formation through a direct, exogenously-triggered
innate response to HDM allergen exposure [3], this effect of
BzATP, poly i:c or CL 097 was unanticipated and implies
that downstream from pannexon opening and ATP release
there is an endogenous trigger for the activation of
prothrombin. Notwithstanding the uncertain identity of
this trigger, this led us next to consider the possibility of a
mechanistic linkage between these events and other innate
receptor systems.
TLR4 is activated by responses to Der p 1 and by
ligation of TLR3 or TLR7
Activation of ROS production in airway epithelial cells by
mixed HDM allergens from D. pteronyssinus was exten-
sively inhibited by SGUL 1733, a potent and selective ADI
compound which inhibits Der p 1 (Fig. 8A,B). Given the
prothrombinase nature of Der p 1 [3] and that the
thrombin substrate fibrinogen and its cleavage products
are putative endogenous ligands of TLR4 [21, 22] we were
interested to investigate whether TLR4 transduced ROS
generation by HDM allergens (i.e., Der p 1).
Figure 8C shows that responses to mixed HDM allergens
or purified Der p 1 (at a concentration matching that in the
complete allergen mixture) were blocked in an identical
manner by TAK-242, a compound which prevents binding
of the TIRAP and TRAM adaptor proteins to cys747 in
TLR4 [23]. The similarity in the inhibition profiles
reinforce the key role in TLR4 activation played by Der
p 1 compared to other component HDM allergens that was
3
Figure 2. ROS production is stimulated by CL 097. (A) Concentration-dependent effect of CL 097 referenced to the effect of BzATP (P< 0.05 v control
(veh)). (B) Inhibition of CL 097 by cycloheximide andmonensin pre-treatment (P< 0.05 v veh, P< 0.05 vCL097). (C) Lack of effect of CP 690550 onCL
097 response (P< 0.05 v veh). Inhibition of CL 097 by, D, AZ 10606120 (P< 0.05 v veh, †P< 0.05 v CL 097, ‡P< 0.05 v veh), E, gene silencing of
pannexin-1 (PNX-1) (P< 0.05 v veh, †P< 0.05 v CL 097 with or without transfection control (con), P< 0.05 v veh), or F, TLR7 (P< 0.05 v veh,
†P< 0.05 vCL 097with or without transfection control). Inset images in E,F show immunoblots of pannexin-1 or TLR7 in cells transfectedwith the target
siRNA (PNX-1, TLR7) or control siRNA (con).
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Figure 3. ROS production byHDMallergenmixture or poly i:c is dependent onmyosin light chain kinase activity. Inhibition byML7 of ROS generation by,
A, mixed HDM allergens (P< 0.05 v veh, P< 0.05 v veh, †P< 0.05 v HDM 1), (B) poly i:c (P< 0.05 v veh, †P< 0.05 v poly i:c), (C) CL 097 (P< 0.05 v
veh, †P< 0.05 vCL 097, P< 0.05 v veh). Effects of glycyl H1152 on responses to, D, mixed HDM allergens (P< 0.05 v veh, †P< 0.05 vHDM1), (E) poly
i:c (P< 0.05 v veh, †P< 0.05 v poly i:c), and (F) CL 097 (P< 0.05 v veh).
J. Zhang et al. TLR4, TLR3, and allergens in ROS generation
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Figure 4. Modulation ofMYLK activity inhibits intracellular ROS production in airway epithelial cells. (A–C) Knockdown ofMYLK blocks ROS generation
by HDM allergens, poly i:c or CL 097. For each stimulant P< 0.05 v appropriate vehicle (veh), †P< 0.05 v corresponding stimulant in non-transfected
cells, ‡P< 0.05 v appropriate stimulant with or without control (con) transfection. (D–F) Formoterol inhibits responses to HDM allergens, CL 097 or poly i:
c. P< 0.05 v veh for each agonist control. Inhibition by formoterol was significant (P< 0.05) over the range 10  12–10  8Mwith HDMallergenmixture or
poly i:c activation and between 10  13 and 10  9M with CL 097.
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Figure 5. Continued.
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suggested by the experiments in Figure 8A,B. We next
examined the effect of TLR4 gene silencing on the response
to mixed allergens (Fig. 8D). The response was inhibited,
providing additional confidence that the mechanism was
operating through TLR4. Silencing of prothrombin had a
similar inhibitory effect (Fig. 8D).
The finding that poly i:c and CL 097 operated
intracellular ROS production in an argatroban-sensitive
and prothrombin-dependent manner (Fig. 7) was surpris-
ing and prompted examination of whether ROS produc-
tion through TLR3- or TLR7-dependent routes also
involved TLR4. We found that responses to poly i:c, CL
097 BzATP and UTP were reduced in cells in which TLR4
was inhibited by TAK-242 or silenced by siRNA (Fig. 9A–
F). This is consistent with a cyclical pathway which
regenerates itself via thrombin formation as previously
reported for HDM/Der p 1 [3, 6]. Silencing of TLR4 was
less effective against poly i:c then for other stimuli
(Fig. 9E), but the significance of this is unclear.
Discussion
This study provides the first mechanistic linkage between a
globally important inhalant allergen, the stimulation of viral
RNA sensor TLRs, the activation of TLR4 and the
intracellular generation of ROS in human airway epithelial
cells. By combining physical presentation with non-
dispensable signaling events, the airway epithelium has a
decisive role in networking the connection between innate
and acquired immune responses to inhaled threats through
communication with dendritic cells and, thereby, T-
lymphocytes [1, 17, 19, 20, 24–26]. Our findings newly
identify that the protease allergen Der p 1, recently revealed
to be a prothrombinase [3], or signaling from either TLR3 or
TLR7 eventuates in the activation of TLR4 through steps
regulated by MYLK and ROCK and which require the gating
of pannexons, purinoceptor signaling and endogenous
thrombin formation. Pannexon opening is crucial to both
the allergen and viral RNA sensor activation mechanisms,
indicating that signaling convergence occurs upstream from
this step.
Our previous work showed that additional to the
generation of ROS through TLR3, poly i:c also stimulated
ROS formation through MDA-5 and RIG-I [3], suggesting
that signaling through these transducers also involves
pannexon gating and thus pathway convergence. Our
present understanding of the pathways is summarized in
Figure 10 which defines a context for the more detailed
kinetic investigations that will be necessary to confirm
mechanisms, fully understand the provenance of ROS being
generated and further explore contributions to the estab-
lishment and exacerbation of allergic airways disease. The
convergence of signaling pathways activated by an innate
response to RNA viruses (which is protein synthesis and
transport-dependent [3]), with the pathway arising from the
thrombin-dependent activation of PAR 1 and PAR 4 by Der
p 1 (which is less dependent on protein synthesis and
transport [3]) is noteworthy for several reasons. Interactions
between inhalant allergens and respiratory viruses are risks
for the initiation of asthma exacerbations [8, 27], and viral
replication induces epithelial remodeling and mucous
metaplasia [28]. It will therefore be of particular interest,
although technically challenging, to investigate the opera-
tion of these events in humans with active disease. This study
provides an embarkation point for those studies.
Within the constellation of HDM allergens the Group 1
cysteine proteases, exemplified by Der p 1, identify as the
principal components possessing the bioactivity responsible
for the generation of intracellular ROS [3]. This arises from
their prothrombinase nature which leads to PAR activation
with the subsequent generation of ROS [3]. Herein, we
demonstrated that SGUL 1733, an ADI which targets Group
1 HDM allergens, blocked ROS generation by a natural
mixture of D. pteronyssinus HDM allergens, as did
pharmacological inhibition or gene silencing of TLR4.
Whereas TLR4 is conventionally regarded as a receptor for
exogenous ligands such as bacterial lipopolysaccharides
(LPS), the blockade by SGUL 1733 shows that any role for
canonical activation by LPS in this system is nugatory, and
indeed our previous work has shown that the allergen-
dependent ROS generation occurs below the threshold for
LPS responses [6]. Activation of TLR4 may also occur
through the formation of endogenous ligands, among which
3
Figure 5. ROS generation by poly i:c requires ADAM 10 and EGFR activation. (A) Inhibition of responses to long poly i:c by GI 254023X (P< 0.05 v
vehicle (veh), †P< 0.05 v poly i:c). (B) Inhibition of responses to short poly i:c by GI 254023X (P< 0.05 v veh, †P< 0.05 v poly i:c). (C) AG 1478 inhibits
responses to poly i:c (P< 0.05 v veh, †P< 0.05 v poly i:c). (D) AG 1478 inhibits responses to BzATP (P< 0.05 v veh, †P< 0.05 v BzATP). (E) Inhibition of
responses to BzATP by GI 254023X (P< 0.05 v veh, †P< 0.05 v BzATP). (F) Silencing of ADAM 10 (A10) or EGFR by siRNA blocks ROS generation by
BzATP and poly i:c. For BzATP: P< 0.05 v veh, P< 0.05 v BzATP in non-transfected or transfection control (con) cells. For poly i:c: P< 0.05 v veh,
†P< 0.05 v poly i:c in non-transfected cells, ‡P< 0.05 v poly i:c with or without control transfection. (G) Response to poly i:c is inhibited by silencing of
ADAM 17 (P< 0.05 v veh, †P< 0.05 v poly i:c without transfection, ‡P< 0.05 v poly i:c with and without control transfection, respectively and
P< 0.05 v veh). Inset images in F and G show immunoblots of ADAM 10, EGFR or ADAM 17 in cells transfected with the relevant target siRNA (A10,
EGFR, A17) or control siRNA (con).
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Figure 6. ROS generation by CL 097 requires ADAM 10 and EGFR activation. (A) Inhibition of CL 097 by GI 254023X (P< 0.05 v veh, †P< 0.05 v
CL 097). (B and C) Attenuation of responses to CL 097 by silencing of ADAM 10 or EGFR (P< 0.05 v veh, †P< 0.05 v CL 097 with or without
control (con) transfection. Inset images in B and C show immunoblots of ADAM 10 or EGFR in cells transfected with target siRNA or control
siRNA (con).
J. Zhang et al. TLR4, TLR3, and allergens in ROS generation
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are the thrombin substrate fibrinogen and its cleavage
products [21, 22, 29]. Most fibrinogen is synthesized by the
liver, but airway epithelial cells—from which it is secreted
vectorially in a microtubule-dependent manner—are an
additional source of all three of its component chains [30].
Notably, fibrinogen cleavage products and TLR4 activation
account for the development of pathophysiological markers
of allergic responses in mice exposed to proteases derived
from Aspergillus oryzae [31]. This encourages a parallel with
HDM where a role for fibrinopeptides in intracellular ROS
generation is suggested by various facets of our data,
particularly the susceptibility of TLR3-, TLR7-, and
purinoceptor-evoked responses to the silencing of pro-
thrombin expression or the direct inhibition of thrombin.
However, ensemble participation of other endogenous TLR4
ligands cannot be excluded and further insight will require
an examination of candidate ligands released from epithelial
cells by thrombin or the ‘‘sheddase’’ activity of ADAM 10
which is an additional component of these responses [6].
In mice, the expression of TLR4 on epithelial cells is
required for the development of allergic sensitization to
HDM [12] and its ligation leads to an activation of cells by
Figure 7. Intracellular ROS formation by poly i:c or CL 097 requires thrombin formation. (A and B) Inhibition by argatroban (P< 0.05 v vehicle (veh),
†P< 0.05 v poly i:c or CL 097). (C andD) Knockdownof prothrombin (PT) expression by siRNAblocks ROS generation in response to BzATP, poly i:c andCL
097 (P< 0.05 v veh, †P< 0.05 v agonists in non-transfected or transfection control (con) cells).
TLR4, TLR3, and allergens in ROS generation J. Zhang et al.
14 © 2018 The Authors. Immunity, Inflammation and Disease Published by John Wiley & Sons Ltd. Published by Wiley Periodicals, Inc.
IL-1a culminating in the release of GM-CSF and IL-33 [13].
Neutralization of any component of this cytokine triad or
deletion of TLR4 thwarts the progression from an innate
response to the development of allergic sensitisation [12, 13],
but despite these insights it is not apparent how HDM
allergens activate epithelial TLR4 to trigger this progression.
Similarity between the HDM allergen Der p 2 and myeloid
differentiation protein-2 (MD-2, lymphocyte antigen 96), a
co-receptor protein for LPS responses, has been assumed to
implicate LPS and Der p 2 as key determinants of why TLR4
activation is essential for the development of allergy to
HDM, and this is consistent with the ability of LPS to drive
allergic immunity under certain conditions [32, 33].
However, our data suggest an alternative explanation where
the critical step is thrombin formation by the direct
prothrombinase activity of Group 1 HDM allergens which
then enables endogenous TLR4 ligand generation in the
airway epithelium. In mice, inhibition of the proteolytic
activity of Der p 1 prevents the development of sensitization
to mixed HDM allergens or unrelated bystanders which rely
on collateral priming for allergic responses [34–37], a result
which suggests that any involvement of Der p 2 and/or LPS
in determining allergic sensitization is dispensable in the
presence of protease allergens. Moreover, it is noteworthy
that purified Der p 2 fails to emulate the production of
intracellular ROS by mixed HDM allergens [3] which, as
Figure 8. (A and B) Generation of ROS in calu-3 cells by HDM allergens and its inhibition by allergen delivery inhibitor SGUL 1733. Panel A shows
progress curves for ROS production in vehicle-treated cells (black circles), cells treated with HDM 0.1 (purple triangles) and HDM-treated cells in the
presence of SGUL 1733 (red squares). Panel B shows the corresponding initial rates of ROS formation (P< 0.05 v veh, P< 0.05 vHDM 0.1). Data from
quadruplicate observations thrice replicated. (C) Inhibition of responses tomixedHDMallergens (purple circles) or purifiedDer p 1 (blue triangles) by TAK-
242. All drug effects are P< 0.05 v the relevant positive control. Baseline ROS production in the absence or presence of TAK-242 are shown in the bar
chart, together with the positive control responses for the stimuli (P< 0.05 v negative controls). (D) Cell silencing of prothrombin (PT) or TLR4 inhibits the
response to mixed HDM allergens (P< 0.05 v vehicle (veh), P< 0.05 v HDM 1 with or without control (con) transfection, †P< 0.05 v HDM 1 in non-
transfected cells).
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Figure 9. (A and B) TAK-242 inhibits ROS generation by BzATP or UTP. The bar charts show the corresponding negative and positive controls (P< 0.05 v
vehicle (veh)). The effects of TAK-242 were statistically significant at 10  7M and higher. (C and D) Cell silencing of prothrombin (PT) or TLR4 attenuates
responses to BzATP or UTP (P< 0.05 v veh; P< 0.05 v BzATP or UTP in non-transfected cells or transfection controls, †P< 0.05 v response in non-
transfected cells, ‡P< 0.05 v veh). (E and F) Cell silencing of TLR3 or TLR4 inhibits responses to poly i:c or CL 097 (P< 0.05 v veh, P< 0.05 v non-
transfected cells or transfection controls, †P< 0.05 v CL097 in non-transfected cells or transfection controls, ‡P< 0.05 v veh).
TLR4, TLR3, and allergens in ROS generation J. Zhang et al.
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demonstrated herein, is a TLR4-dependent response
dominated by the proteolytic action of Der p 1.
Surprisingly, pharmacological and gene-silencing experi-
ments revealed that ROS generation by poly i:c and CL 097
also stimulated thrombin formation and resulted in
sustained, TLR-4 dependent intracellular ROS generation.
The clear implication is that supplemental to an exogenous
prothrombinase (i.e., Der p 1) which triggers ROS
production, downstream signaling unleashes endogenous
prothrombinase activity as a transductional mode which
leads to TLR4 ligand generation. Intracellular ROS genera-
tion in airway epithelial cells by HDM allergen or viral RNA
sensor activation thus share, through confluent signaling,
pleiotropic operational elements (thrombin, ADAM 10,
EGFR, TLR4) fundamental to the progression of allergic
sensitization and asthma exacerbations.
ROS are compelling mediators of interactions between
allergens and viruses through direct and indirect effects on
gene expression [7] or the release of constitutively expressed
regulators of type 2 innate immune responses [38–40]. Of
interest in the latter regard is IL-33 which is implicated in
asthma susceptibility by genome-wide association studies
and whose ROS- and EGFR-dependent release is enhanced
in asthma [9, 41, 42]. Like IL-4 and IL-13 [10], IL-33
suppresses innate antiviral immunity [8] and is thus part of a
signaling nexus which links key allergens with inflammatory
signaling from viruses.
Our data highlight a significant role for pannexons in the
confluent signaling response through which Der p 1 and viral
RNA sensors generate intracellular ROS. In non-excitable
cells pannexons have a low open probability and, in contrast
to excitable tissues, membrane potential is unlikely to
control their gating. Various actions may lead to pannexon
opening in non-excitable cells but their significance,
especially under physiological conditions, remains an area
of uncertainty and thus active interest [43]. These actions
include proteolytic cleavage of the intracellular C-terminus
of pannexin-1 by caspase 3 or caspase 7 which, because the
Figure 10. Schematic representation of ROS production initiated by Group 1 HDM protease allergens or viral RNA sensor ligation based on current
understanding from data described in the present study and earlier work, as indicated. The activation of TLR4 occupies a central role in ROS generation
initiated by signals of either origin. Kinetic studies will be necessary to confirm the reaction sequence and additional work investigating reaction
participants in key steps (e.g., the ligation of EGFR and TLR4) are required. Other unresolved issues concern the subcellular provenance of ROS generation
and cross-talk between different mechanisms, the conditional operation of pannexons for ATP release and why signaling at this stage appears to involve
both G-protein-coupled and ligand-gated ion channel purinoceptors.
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C-terminus of each pannexin-1 protein normally occludes
the lumen of the pannexon hexamer, results in a
constitutively open channel that commits the cell to
apoptosis [44–46].
Mechanical stimulation triggers calcium flux and opens
pannexons as demonstrated in cells that have been
artificially swollen and stretched [47–49]. Thus, other
types of stress-related activation could be anticipated. In
airway epithelial cells, Der p 1 evokes changes in the actin
cytoskeleton which accompany the cleavage of tight
junctions (TJs) and the concomitant non-specific increase
in epithelial permeability [19]. This association initially
suggested that the cytoskeletal changes arose because TJ
cleavage initiated outside-in cellular signaling which
triggered apoptosis [18, 20]. However, the cytoskeletal
changes are widespread across an epithelial surface exposed
to HDM allergens, whereas apoptosis occurs
discretely [20]. Moreover, apoptosis occurs in cells
constitutively lacking TJs, or after their removal [20],
indicating that the cytoskeletal rearrangements occur
through other mechanisms with different consequences.
This prompted us to consider mechanical stress arising
from actomyosin contractility as a mode of pannexon
opening in cells activated by HDM allergens or by ligation
of virus-sensing TLRs. While our findings show that
enzymes which control the phosphorylation state of
myosin light chains, and which thus affect the operation
of myosin motors, have striking effects on ROS production
by these stimuli, a limitation of our study is the absence of
direct measures of myosin phosphorylation. Thus, further
work with other approaches will be required to confirm
our conclusions.
Our new data implicate both ADAM 10 and EGFR in ROS
generation after TLR3/TLR7 ligation (Fig. 10). ADAM 10 is
pertinent to the development of allergy through multiple
mechanisms [50–52]. Our previous work with Der p 1
suggested that ADAM 10 activation lies downstream from
ATP release and amplifies the conversion of prothrombin to
thrombin [6]. The present studies demonstrate that this
amplification also occurs after ligation of TLR3 or TLR7 and
is thus a distinct endogenous cellular mechanism for
thrombin formation in which ADAM 10 behaves directly
or indirectly as a prothrombinase, mirroring snake venom
proteases of family M12B to which it is related.
This concept of an essential endogenous prothrombi-
nase-dependent step (Fig. 10) provides a new understand-
ing of our forerunner work which established that ROS
production triggered by TLR3 ligation is blocked by PAR 1
antagonists [3]. The new findings further support
intracellular ROS production by Der p 1 or TLR3/TLR7
ligation being a cyclical chain reaction which features
extensive receptor cross-talk. This cyclical nature creates
the potential for its regenerative operation through
thrombin formation. Reasons for the dual involvement
of thrombin-sensitive PARs and the thrombin-dependent
activation of TLR4 are currently unclear, but a plausible
hypothesis under investigation is that the PAR-mediated
responses may terminate quickly due to receptor internal-
isation, whereas TLR4 stimulation facilitates a prolonged,
recycling activation that is characteristic of the cellular
behavior observed. Key questions about this nexus remain
unresolved, not least the mechanistic details of its
operational control in which defining the key oxidants
and their provenance will be key.
In summary, our findings indicate that the gating of
pannexons and TLR4 ligation are key to innate oxidative
stress responses to a proteolytic inhalant allergen of clinical
significance. This provides an unexpected link to mecha-
nisms operated by the ligation of receptors known to be
activated by respiratory viruses whose inflammatory effects
are associated, at least part, with the exacerbation of asthma.
The linkage between these events and their expected
consequences suggest that novel inhibitors of Group 1
HDM allergens, exemplified here by SGUL 1733, may have
useful profiles as novel therapies for asthma and allied
allergic conditions. Clearly, it will now be interesting to
examine these pathways in the context of active viral
infections.
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